Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triapine + Gemcitabine in Metastatic NSCLC
NCT00064064Phase 2Completed
- Sponsor
- Vion Pharmaceuticals
- Start
- Jan 2003
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2, open-label, single-arm trial of triapine, sponsored by Vion Pharmaceuticals. Primary endpoint: Objective Response Rate. Started Jan 2003; status: completed.
02
Drugs
triapine
Beyond the preview
Go deeper on NCT00064064.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00064064.